Journal ONCOLOGY: Table of Contents

Rituximab as a Single Agent and in Combination With Interferon Alfa-2a as Treatment of Untreated and First-Relapse Follicular or Other Low-Grade Lymphomas: A Randomized Phase II Study (M 39035)

Relapsed Follicular Lymphoma: Response to a Fludarabine/Mitoxantrone Regimen and the Monoclonal Anti-CD20 Antibody Rituximab

Novel Approaches in the Treatment of Non-Small-Cell Lung Cancer

Update on Chemotherapy for Advanced Colorectal Cancer

Imaging Prostate Cancer: Current and Future Applications

Triplet Combination Chemotherapy and Targeted Therapy Regimens

Commentary (Frank): Gene Therapy for Head and Neck Cancers

Phase II Study of Rituximab in Combination With Fludarabine in Patients With Low-Grade or Follicular B-Cell Lymphoma

Gemcitabine and Nonplatinum Combinations in Non-Small-Cell Lung Cancer

Gemcitabine for the Treatment of Non-Small-Cell Lung Cancer

Ibritumomab Tiuxetan Radioimmunotherapy Improves Quality of Life in Patients With Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

Camptothecin Schedule and Timing of Administration With Irradiation

Irinotecan Plus Cisplatin in Advanced Gastric or Gastroesophageal Junction Carcinoma

Final Results of a Randomized Controlled Study of the Ibritumomab Tiuxetan Radioimmunotherapy Regimen vs a Standard Course of Rituximab Immunotherapy for B-Cell Non-Hodgkin’s Lymphoma

Combination Fludarabine, Cyclophosphamide, and Rituximab for Previously Treated Patients With Chronic Lymphocytic Leukemia

Irinotecan/Gemcitabine Combination Chemotherapy in Pancreatic Cancer

Rituximab Plus CHOP Is Superior to CHOP Alone in Elderly Patients With Diffuse Large B-Cell Lymphoma: Interim Results of a Randomized GELA Trial

Phase I Study of Interleukin-12 in Combination With Rituximab in Patients With B-Cell Non-Hodgkin’s Lymphoma

Current Status of Oral Chemotherapy for Colorectal Cancer

Peripheral Blood B-Cell Recovery in Patients With Non-Hodgkin’s Lymphoma Treated With Rituximab Does Not Correlate With Onset of Disease Progression

Imaging Prostate Cancer: Current and Future Applications

Self-Referral Rules Finalized by HCFA

Systemic Therapy for Older Women With Breast Cancer

Gemcitabine in Combination With New Platinum Compounds: An Update

Cancer Nursing: Principles and Practice, 5th Edition

Rituximab: Sustained Remissions in Patients With Relapsed or Refractory Low-Grade or Follicular Non-Hodgkin’s Lymphoma

Children’s Guide to Bone Marrow Transplants Receives a Gold Award

Gene Therapy for Head and Neck Cancers

Oral Chlorambucil and Prednisone With Rituximab as Initial Chemotherapy for Low-Grade Non-Hodgkin’s Lymphoma: A Phase II Trial

Thalidomide Analogs Active Against Multiple Myeloma

Iodine-131 Tositumomab for Patients With Low-Grade or Transformed Low-Grade Non-Hodgkin’s Lymphoma: Complete Response Data

Brachytherapy for Carcinoma of the Lung

Preliminary Report of Rituximab With Intensive Chemotherapy for Untreated Aggressive Mantle Cell Lymphoma

Efficiency of In Vivo Purging With Rituximab Followed by High-Dose Therapy With Autologous Peripheral Blood Stem Cell Transplantation in B-Cell Non-Hodgkin’s Lymphomas: A Single-Institution Study

Phase II Study of Single-Agent Rituximab in Previously Treated Multiple Myeloma Patients: Patients With CD20-Positive Bone Marrow Plasma Cells May Derive Benefit From Rituximab

COX-2 Inhibition in Clinical Cancer Prevention

Systemic Therapy for Older Women With Breast Cancer

Bexarotene May Extend Survival in Lung Cancer Patients

High Complete Remission Rate in Chemotherapy-Refractory Classic or Variant Hairy Cell Leukemia Induced by the Anti-CD22 Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22)

A Pilot Study of Anti-CD20 Monoclonal Antibody Rituximab in Patients With Refractory Immune Thrombocytopenic Purpura

Efficacy and Safety of Tositumomab/Iodine-131 Tositumomab in the Expanded Access Study: Interim Report From Two Institutions

New Rule on Medical Record Confidentiality

Treatment of Elderly Patients With Non-Small-Cell Lung Cancer

Empiric Antifungal Therapy for the Neutropenic Patient

A Pilot Study of Rituximab in Patients With Relapsed Hodgkin’s Disease of Classical Type

Gemcitabine and Cisplatin Combination in Early-Stage Non-Small-Cell Lung Cancer

Empiric Antifungal Therapy for the Neutropenic Patient

Treatment of Relapsed B-Cell Non-Hodgkin’s Lymphoma With a Combination of Chimeric Anti-CD20 Monoclonal Antibodies (Rituximab) and G-CSF: Final Report on Safety and Efficacy

Molecular Responses With Fludarabine, Mitoxantrone, and Dexamethasone Plus Rituximab Chemoimmunotherapy for Stage IV Indolent Follicular Non-Hodgkin’s Lymphoma

Future Directions in Adjuvant Therapy for Stage III Colon Carcinoma

Monoclonal Anti-CD20 Antibody Rituximab for Treatment of CD20-Positive Hodgkin’s Lymphoma: The German Experience

Imaging Prostate Cancer: Current and Future Applications

Tositumomab/Iodine-131 Tositumomab for Non-Hodgkin’s Lymphoma Patients Who Progressed After Treatment With Rituximab: Results of a Multicenter Phase II Study

Systemic Therapy for Older Women With Breast Cancer

Ibritumomab Tiuxetan Radioimmunotherapy Is Safe and Well Tolerated in Patients With Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma

Empiric Antifungal Therapy for the Neutropenic Patient

Rituximab in the Treatment of Autoimmune Hemolytic Anemia

Current Clinical Trials in Small-Cell Lung Cancer

Trends in Cigarette Smoking Among High School Students: United States, 1991-19

Optimizing Chemoradiation in Locally Advanced Non-Small-Cell Lung Cancer

Cisplatin and Irinotecan in Upper Gastrointestinal Malignancies

Epratuzumab (Anti-CD22 Humanized Monoclonal Antibody) Is an Active and Well-Tolerated Therapy for Refractory/Relapsed Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

FDA Grants Marketing Clearance for New Formulation of Fluorouracil

Combination Chemo-Antibody Therapy With Fludarabine, Cyclophosphamide, and Rituximab Achieves a High Complete Remission Rate in Previously Untreated Chronic Lymphocytic Leukemia

State of the Art of Non-Small-Cell Lung Cancer in the New Millennium

Irinotecan in Gastrointestinal Malignancies

Noninherited Genetic Alteration Discovered for Breast and Ovarian Cancers